CpG island hypermethylation of tumor-suppressor genes in H. pylori-infected non-neoplastic gastric mucosa is linked with gastric cancer risk

Helicobacter
Mitsuru KaiseHisao Tajiri

Abstract

Gastric carcinogenesis involves CpG island hypermethylation (CIHM) of tumor-suppressor genes. Although the CIHM of these genes occurs in non-neoplastic gastric cells, it is unclear whether this epigenetic alteration is linked with aging and/or gastric cancer risk. We investigated this linkage in noncancerous gastric mucosa infected with H. pylori. Noncancerous corpus mucosa was endoscopically obtained from H. pylori-positive gastric cancer patients (n = 34), and age-matched H. pylori-positive noncancerous controls (n = 68). Genomic DNA retrieved from the mucosa was subjected to methylation-specific polymerase chain reaction for p16, Ecad, and DAPK genes. Linkage between CIHM and clinicopathologic factors was evaluated. CIHM rates of DAPK, Ecad, and p16 promoters were significantly higher in noncancerous gastric mucosa of gastric cancer patients (91, 88, and 68%, respectively) than in noncancerous controls (71, 53, and 25%, respectively). Multivariate regression analysis showed a significant linkage between CIHM in noncancerous mucosa and coexistence of gastric cancer. Significant linkage between polymorphoneutrophil infiltration and CIHM was observed except for CIHM of p16. No linkage was observed between CIHM and other paramet...Continue Reading

References

Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·J G HermanS B Baylin
Mar 30, 1999·International Journal of Cancer. Journal International Du Cancer·B ShannonB Iacopetta
Jul 27, 2000·Annals of the New York Academy of Sciences·J P Issa
Sep 15, 2001·The New England Journal of Medicine·N UemuraR J Schlemper
Apr 20, 2002·Current Opinion in Infectious Diseases·L A Allen
May 16, 2002·Journal of the National Cancer Institute·Lanlan ShenJean-Pierre J Issa
Aug 7, 2002·The American Journal of Pathology·Takayoshi WakiTeiichi Motoyama
Aug 7, 2002·The Journal of Nutrition·Mihai D Niculescu, Steven H Zeisel
Apr 3, 2003·Nature Reviews. Cancer·Peter W Laird
Nov 25, 2003·The New England Journal of Medicine·James G Herman, Stephen B Baylin
Feb 10, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takao MaekitaToshikazu Ushijima
Feb 24, 2006·Nature Reviews. Cancer·Stephen B Baylin, Joyce E Ohm
Nov 23, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Takeshi NakajimaDaizo Saito

❮ Previous
Next ❯

Citations

Dec 4, 2009·Carcinogenesis·Aaron J SchetterCurtis C Harris
Oct 5, 2010·Journal of Lower Genital Tract Disease·Susana AidéMaria da Glória Costa Carvalho
Mar 1, 2012·Journal of Lower Genital Tract Disease·Susana AidéMaria da Glória Costa Carvalho
Jun 19, 2012·Expert Review of Molecular Diagnostics·Tomomitsu Tahara, Tomiyasu Arisawa
Jan 27, 2016·BMC Cancer·Rita Kupcinskaite-NoreikieneElona Juozaityte
Sep 12, 2008·Helicobacter·António Carlos FerreiraYoshio Yamaoka
Jan 26, 2010·International Journal of Cancer. Journal International Du Cancer·Lifang HouAndrea Baccarelli
Feb 24, 2010·International Journal of Cancer. Journal International Du Cancer·Barbara G SchneiderWael El-Rifai
Feb 26, 2010·Cellular Microbiology·Françoise I BussièreEliette Touati
Jun 17, 2015·Epigenomics·Tomomitsu Tahara, Tomiyasu Arisawa
Feb 28, 2015·Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology·Nabil Ben Chaabane, Hamad Saadoon Al-Adhba
Oct 31, 2012·Korean Journal of Pathology·Gyeong Hoon Kang
Aug 30, 2016·Journal of Genetics and Genomics = Yi Chuan Xue Bao·Shawal SpencerDagmar Wirth
May 28, 2014·Gastrointestinal Endoscopy·Mihir PatelMichael Wallace
Feb 7, 2018·Frontiers in Microbiology·Paula DíazAndrew F G Quest
Dec 17, 2008·Digestive Diseases and Sciences·Tomomitsu TaharaTomiyasu Arisawa
Feb 3, 2009·Digestive Diseases and Sciences·Tomomitsu TaharaTomiyasu Arisawa
May 22, 2019·Cancer Causes & Control : CCC·Geetanjali SainiRitu Aneja
Dec 18, 2015·World Journal of Gastroenterology : WJG·Yue-Feng TongJian-Zhong Zhang
Dec 17, 2015·World Journal of Gastroenterology : WJG·Manuel A ValenzuelaAndrew F G Quest
May 18, 2016·World Journal of Gastroenterology : WJG·Roberto Herrera-GoepfertRodrigo González-Barrios
Nov 11, 2017·Nature Communications·Thomas FleischerVessela N Kristensen
Sep 12, 2020·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Hee Jin KimDong Ho Lee
Oct 18, 2020·BMC Medical Genetics·Hikaru TakanoTomiyasu Arisawa
Apr 4, 2021·International Journal of Molecular Sciences·Amira FitiehIsmail Hassan Ismail

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Takao MaekitaToshikazu Ushijima
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Takeshi NakajimaDaizo Saito
Journal of Biochemistry and Molecular Biology
Toshikazu Ushijima
© 2021 Meta ULC. All rights reserved